Abstract 16213: No Cardiac Benefit After Single Dose of Intramyocardial or Intravenous Mesenchymal Stem Cell-Derived Extracellular Vesicles Post-Myocardial Infarction Supports Need for Bioengineered Extracellular Vesicles With Non-Invasive Cardiac Uptake

Authors

Mark Broadwin MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2023

Volume

148

Issue

1

Published In/Presented At

https://doi.org/10.1161/circ.148.suppl_1.16213

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery, Fellows and Residents

Document Type

Article